These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 19109042)
21. Effects of vincristine treatment on semen quality in a dog with a transmissible venereal tumour. Gobello C; Corrada Y J Small Anim Pract; 2002 Sep; 43(9):416-7. PubMed ID: 12238508 [TBL] [Abstract][Full Text] [Related]
22. Follow-up on chemotherapy of venereal tumors. Brown NO; MacEwen EG; Clavert C J Am Vet Med Assoc; 1980 Oct; 177(8):676. PubMed ID: 7440361 [No Abstract] [Full Text] [Related]
23. Transmissible venereal tumor of the uterine stump following successful chemotherapy in a 5-year-old mixed-breed dog. Ball E; Hoddinott K Can Vet J; 2024 Jul; 65(7):632-637. PubMed ID: 38952767 [TBL] [Abstract][Full Text] [Related]
24. Vincristine-associated total antioxidant and oxidant status of ovaries and in vitro nuclear oocyte maturation in dogs with canine transmissible venereal tumor. Özalp GR; Üstüner B; Avci G; Bari Ö; Yılmaz MM; Denk B; Aktar A Anim Reprod Sci; 2023 Jun; 253():107260. PubMed ID: 37196377 [TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacokinetics and effects of vincristine sulfate in dogs with transmissible venereal tumor (TVT). Hantrakul S; Klangkaew N; Kunakornsawat S; Tansatit T; Poapolathep A; Kumagai S; Poapolathep S J Vet Med Sci; 2014 Dec; 76(12):1549-53. PubMed ID: 25649934 [TBL] [Abstract][Full Text] [Related]
27. Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor. Frampton D; Schwenzer H; Marino G; Butcher LM; Pollara G; Kriston-Vizi J; Venturini C; Austin R; de Castro KF; Ketteler R; Chain B; Goldstein RA; Weiss RA; Beck S; Fassati A Cancer Cell; 2018 Apr; 33(4):620-633.e6. PubMed ID: 29634949 [TBL] [Abstract][Full Text] [Related]
28. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy. Javanbakht J; Pedram B; Taheriyan MR; Khadivar F; Hosseini SH; Abdi FS; Hosseini E; Moloudizargari M; Aghajanshakeri SH; Javaherypour S; Shafiee R; Emrani Bidi R Tumour Biol; 2014 Jun; 35(6):5493-500. PubMed ID: 24557542 [TBL] [Abstract][Full Text] [Related]
29. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases. Papazoglou LG; Koutinas AF; Plevraki AG; Tontis D J Vet Med A Physiol Pathol Clin Med; 2001 Sep; 48(7):391-400. PubMed ID: 11599677 [TBL] [Abstract][Full Text] [Related]
30. Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma. Spugnini EP; Dotsinsky I; Mudrov N; Citro G; D'Avino A; Baldi A J Exp Clin Cancer Res; 2008 Nov; 27(1):58. PubMed ID: 18980687 [TBL] [Abstract][Full Text] [Related]
31. Autologous bone marrow infusion following high dose chemotherapy of the canine transmissible venereal tumor (TVT). Epstein RB; Sarpel SC Exp Hematol; 1980 Jul; 8(6):683-9. PubMed ID: 7009184 [TBL] [Abstract][Full Text] [Related]
32. Parvovirus-induced regression of canine transmissible venereal sarcoma. Yang TJ Am J Vet Res; 1987 May; 48(5):799-800. PubMed ID: 3035973 [TBL] [Abstract][Full Text] [Related]
33. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological study of canine transmissible venereal tumour in leishmaniotic dogs. Marino G; Gaglio G; Zanghì A J Small Anim Pract; 2012 Jun; 53(6):323-7. PubMed ID: 22489831 [TBL] [Abstract][Full Text] [Related]
35. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT? do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476 [TBL] [Abstract][Full Text] [Related]
36. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837 [TBL] [Abstract][Full Text] [Related]
37. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response. Flórez MM; Fêo HB; da Silva GN; Yamatogi RS; Aguiar AJ; Araújo JP; Rocha NS Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698 [TBL] [Abstract][Full Text] [Related]
38. A case of ocular canine transmissible venereal tumor. Milo J; Snead E Can Vet J; 2014 Jan; 55(1):1245-9. PubMed ID: 24381345 [TBL] [Abstract][Full Text] [Related]
39. Vincristine sulfate as single-agent chemotherapy in a dog and a cat with malignant neoplasms. Hahn KA J Am Vet Med Assoc; 1990 Aug; 197(4):504-6. PubMed ID: 2211297 [TBL] [Abstract][Full Text] [Related]
40. Regression of canine transmissible venereal sarcoma. Yang TJ J Am Vet Med Assoc; 1987 Jul; 191(1):6. PubMed ID: 3610780 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]